Recommended Pages at ir.unither.com
United Therapeutics Corporation - FDA Approves TYVASO (Treprostinil) Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension
ir.unither.com — “United Therapeutics Corporation - FDA Approves TYVASO (Treprostinil) Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension” View full resource at ir.unither.com
Most Recently Shared on July 31, 2009 at 1:12 pm By:
Dr. Warren Rosenblum Doctor, Internist, Cardiologist, and Physician
FDA approves inhaled Treprostinil (Tyvaso) for the treatment of Pulmonary Hypertension. http://tinyurl.com/kw89ks
